A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY)

חו"ל (דורש נסיעה)מגייס משתתפים

מצבים רפואיים

HER2-positive Advanced Gastric Cancer · HER2-positive Gastroesophageal Junction Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • KABEG Klinikum Klagenfurt am Wörthersee - Landeskrankenanstalten LKH, Klagenfurt, Austria

  • Ordensklinikum Linz GmbH Barmherzige Schwestern, Linz, Austria

  • Universitätsklinikum St. Pölten - Lilienfeld, Sankt Pölten, Austria

  • Medizinische Universität Wien, Vienna, Austria

  • St. Josef Krankenhaus GmbH Ein Unternehmen der Vinzenz Gruppe, Vienna, Austria

  • Klinik Ottakring, Wilhelminenspital der Stadt Wien, Vienna, Austria

  • Kepler Universitätsklinikum, Wels, Austria

  • Landesklinikum Wiener Neustadt, Wiener Neustadt, Austria

  • Krankenhaus St. Vinzenz in Zams, Zams, Austria

  • OLV Hospital Aalst, Aalst, Belgium

  • Imelda vzw, Bonheiden, Belgium

  • HUB institut Jules Bordet, Brussels, Belgium

  • Grand hôpital de Charleroi, Charleroi, Belgium

  • Antwerp University Hospital, Edegem, Belgium

  • UZ Gent, Ghent, Belgium

  • CHU Helora Hospital de La Louvière - Site Jolimont, Haine-Saint-Paul, Belgium

  • JESSA Hasselt, Hasselt, Belgium

  • UZ Brussel, Jette, Belgium

  • UZ Leuven, Leuven, Belgium

  • AZ Delta, Roeselare, Belgium

  • MVZ am Klinikum Aschaffenburg, Aschaffenburg, Germany

  • Universitätsklinikum Augsburg, Augsburg, Germany

  • Vivantes Klinikum im Friedrichshain, Berlin, Germany

  • Charite Campus Benjamin Franklin, Berlin, Germany

  • Klinikum Chemnitz gGmbH, Chemnitz, Germany

  • MV-Zentrum für Hämatologie & Onkologie, Cologne, Germany

  • Universitätsklinikum Düsseldorf, Düsseldorf, Germany

  • University Hospital Essen, Essen, Germany

  • Universitaetsklinikum Giessen und Marburg, Standort Giessen, Giessen, Germany

  • Alb Fils Kliniken GmbH, Göppingen, Germany

  • Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg, Germany

  • Studienzentrum am Raschplatz GbR, Hanover, Germany

  • KRH Klinikum Siloah, Hanover, Germany

  • Gemeinschaftspraxis Dr. Haytham Kamal / Dr. David C. Dorn, Hanover, Germany

  • Städtisches Klinikum Karlsruhe, Karlsruhe, Germany

  • ÜBAG MVZ Mitte / MVZ Delitzsch GmbH, Leipzig, Germany

  • Praxis Hämatologie und Onkologie Magdeburg, Magdeburg, Germany

  • Universitätsklinik für Gastroenterologie, Hepatologie und Infektiologie, Magdeburg, Germany

  • Klinikum rechts der Isar der Technischen Universität München, München, Germany

  • Pi.Tri-Studien GmbH, Offenburg, Germany

  • Klinikum am Steinenberg Reutlingen, Reutlingen, Germany

  • Nädler GmbH, Rinteln, Germany

  • CaritasKlinikum Saarbrücken, Saarbrücken, Germany

  • Praxis Onkologie Rheinsieg, Troisdorf, Germany

  • Universitätsklinikum Würzburg (UKW), Würzburg, Germany

  • AOU delle Marche, Ancona Torrette, Italy

  • ASL AT - Presidio Ospedaliero "Cardinal Massaia", Asti, Italy

  • IRCCS "S. De Bellis", Castellana Grotte, Italy

    Contact: Study coordinator (Principal Investigator)
  • ARNAS Garibaldi - PO Nesima, Catania, Italy

    Contact: Study coordinator (Principal Investigator)
  • AOU Careggi, Florence, Italy

    Contact: Study coordinator (Principal Investigator)
  • IRCCS AOU San Martino, Genova, Italy

    Contact: Study coordinator (Principal Investigator)
  • IRCCS Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Ospedaliero-Universitaria di Modena, Modena, Italy

    Contact: Study coordinator (Principal Investigator)
  • A.O.U. Cagliari - Policlinico Universitario Duilio Casula, Monserrato, Italy

  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • Università degli studi di Napoli Federico II, Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • Università della Campania 'Luigi Vanvitelli', Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • AOU Pisana - Stabilimento Santa Chiara, Pisa, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Sanitaria Locale di Biella - Ospedale degli Infermi, Ponderano, Italy

  • AUSL della Romagna - Ospedale "S. Maria delle Croci" di Ravenna, Ravenna, Italy

    Contact: Study coordinator (Principal Investigator)
  • Policlinico Universitario Campus Bio-Medico, Roma, Italy

    Contact: Study coordinator (Principal Investigator)
  • AO San Camillo Forlanini, Roma, Italy

  • AO San Giovanni Addolorata, Roma, Italy

  • IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

  • AO "Cardinale Giovanni Panico", Tricase, Italy

    Contact: Study coordinator (Principal Investigator)
  • ASU FC - Ospedale "Santa Maria della Misericordia", Udine, Italy

  • Azienda ULSS 8 Berica - Ospedale San Bortolo, Vicenza, Italy

  • ULS Almada-Seixal, Almada, Portugal

  • USL Braga, Braga, Portugal

  • ULS Coimbra, Coimbra, Portugal

  • IPO Lisboa, Lisbon, Portugal

  • CC Champalimaud, Lisbon, Portugal

  • Hospital da Luz, Lisbon, Portugal

  • ULS Santo António, Porto, Portugal

  • Vila Real, Vila Real, Portugal

מובילי המחקר
  • Global Team Leader

    Study Director

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company